济南检查痛风需要多少钱(济南尿酸痛风能吃芥菜吗) (今日更新中)

The family of Jacob Blake is hosting a gathering in Kenosha, Wisconsin on Tuesday ahead of President Donald Trump's visit to the city.The event, which will be held near the site where Blake was shot seven times in the back by a Kenosha police officer, will include a press conference with local officials and family representatives. The event will also include a community clean-up, a food drive, a healing circle, and a voter registration booth.Several days after police officers shot Blake during an Aug. 23 altercation, protests in Kenosha grew violent. The city estimates that million in property damages have been caused by looting and burning amid the unrest.Last Tuesday, 17-year-old Kyle Rittenhouse shot three protesters, two of them fatally, after he drove 20 miles to protect local businesses. Rittenhouse has been arrested in connection with the homicides; his lawyer says that Rittenhouse was shooting in self-defense.In recent days, protests in Kenosha have been peaceful and without incident.The event held by Blake's family comes hours before a visit to the city by President Donald Trump. Several Democratic politicians, including Kenosha's mayor and Wisconsin's governor, have asked Trump to reconsider, saying his presence could stoke more violence in the city.Blake was shot during an altercation with police on Aug. 23. Police say they were responding to a call about a man at a party who "shouldn't have been there."Police attempted to take Blake into custody but say he was non-compliant. Officers say they tried to use stun guns on Blake but could still not take him into custody.Blake had previously told officers he had a knife in his vehicle. At one point during the altercation, as Blake approached his car, Officer Rusten Sheskey shot Blake in the back at least seven times. A knife was later found on the floorboard of the car.Blake is still hospitalized and is paralyzed from the waist down. Sheskey has been placed on administrative leave but has not been charged with a crime. 2020

The Centers for Disease Control and Prevention is asking people who take a COVID-19 vaccine to download a smartphone app so it can continue to track side effects.The app, called V-Safe, uses text messages and web surveys from the CDC to check in with patients who have gotten a COVID-19 vaccine.The app will also remind patients when it's time to go back for a second shot.Patients can expect to experience mild symptoms like fever, headache and muscle aches after taking the vaccine. But doctors, like Dr. Grace Lee — the associate chief medical officer for practice innovation at Stanford Children's Health and a member of the CDC's vaccine advisory panel — say those side effects don't tend to last very long."We hope that patients will be willing to engage in the system, recognizing it does take some time," Lee said. "But it's really important for all of us in the U.S. to make sure that we are helping to create a robust vaccine safety monitoring system for all COVID vaccines."Lee says that because clinical trials for COVID-19 vaccines have been so large — with 30,000 to 60,000 people in each trial, compared to just several thousand for a typical trial — there's already a lot known about the vaccines.The trials have shown no major safety risks thus far, but Lee says rare adverse events can happen — like the two healthcare workers in Alaska earlier this week who suffered anaphylactic allergic reactions with the Pfizer vaccine. The side effects reported by those two patients were similar to the ones suffered by two people in the U.K. earlier this month.Lee says that's why the CDC is counting on as many people as possible to use V-Safe."My hope is that if the numbers are high," Lee said. "It just means it gives us more information more quickly, and so for anything rare that might occur, we would be able to pick it up much more quickly."V-Safe send text messages to patients, asking them how they are feeling for up to six weeks after their shots. The CDC says the questions take less than five minutes to answer and that the information patients provide will be confidential and private. 2117

The destructive storm surge has receded, and the clean up has begun from Hurricane Laura in Texas and Louisiana. But officials along this shattered stretch of Louisiana coast are warning returning residents they will face weeks without power or water amid the hot, stifling days of late summer. Hundreds of thousands of people in two of the hardest-hit states are reported to be without power following the severe storm.The U.S. toll from the Category 4 hurricane stood at 16 deaths, with more than half of those killed by carbon monoxide poisoning from the unsafe operation of generators. President Donald Trump landed in Louisiana Saturday afternoon to tour the damage in Louisiana and will head to Texas next. 720

The Dow Jones Industrial Average continued its volatile run on Monday, closing down 200 points. At one point during the day, the index was about 350 points above its previous close.Struggling tech stocks and fears about trade tariffs have led to selling sprees in the past month. The market is down about 2,000 points from where it opened in October.More on this as it develops. 391

The Food and Drug Administration approved on Wednesday a treatment for the Ebola virus. This is the first FDA-approved treatment for Zaire ebolavirus infection in adults and kids.Zaire ebolavirus is one of four Ebola virus species that can cause potentially deadly infections. It is transmitted through direct contact with blood, tissue or body fluids of an infected person or wild animal.The treatment, Inmazeb, is a mixture of three monoclonal antibodies and was created by Regeneron Pharmaceuticals. The three antibodies work together to bind to the glycoprotein on the surface of the Ebola virus and block it from entry into the body’s cells.Inmazeb was tested in the Democratic Republic of the Congo during an Ebola virus outbreak in 2018-2019 through a partnership between the local government and the National Institutes of Health.A vaccine for Ebola virus was approved by the FDA in December 2019.Regeneron is also the company behind an experimental antibody cocktail that was given to President Donald Trump following his diagnosis of COVID-19, and which he said “cured” him. Trump was also prescribed the antiviral drug remdesivir and the steroid dexamethasone at the time.Regeneron’s COVID-19 treatment is a mix of two powerful antibodies that are believed to boost the immune response to the coronavirus. Early results seem promising, according to initial tests and a press release from the company.The company has submitted an application to the FDA to get emergency approval of their COVID-19 treatment. 1525

来源：资阳报